Zytomed Systems GmbH is a Berlin-based company specialized in the development, production and sales of diagnostic reagents and system solutions for immunohistology, in situ hybridization and molecular pathology.
What we do, we like to do right
Our broad and deeply diversified portfolio of optimally matched reagents is continuously being developed and always marks the latest state of the art in diagnostics and research. With a range of over 8,000 antibodies for histology, histopathology and cell biology, we are one of the leading suppliers in this field in Germany and the German-speaking countries.
We deliver straight away
Development and production of our products are regulated by an ISO 9001:2015 and ISO 13485:2016 certified quality management system. We continuously guarantee excellent quality – which has made us long-standing trusted partners and reliable suppliers to hundreds of laboratories and scientific institutions.
Short delivery times and strict adherence to schedules are just as natural for us as customer proximity and sound advice.
Your concerns are our concerns
We focus our many years of experience, our specialist knowledge and our special expertise on comprehensive, highly qualified personal consulting for our clients and customers. Together, we develop individual solutions tailored to specific needs and accompany their introduction and application in laboratory practice.
We know exactly what we are doing
The comprehensive expertise, many years of experience and specific knowledge of our approximately 50 employees are crucial to our success. In this way, we ensure first-class advice for our clients and customers at all times – both in person on site and via our technical hotline – and continuously invest in the development of our personnel structure and in individual professional training.
Zytomed Systems GmbH is founded by Thomas Dittmer and Kerstin Weyrauch; Dr. Karsten Debel joins as third shareholder and CEO.
Start of production of IHC reagents at the Bargteheide branch, ISO 9001 and ISO 13485.2008 certification.
Start of sales activities in the European and non-European economic area.
Opening of the new Zytomed Systems GmbH business premises in Berlin.
Expansion of the Bargteheide branch by a new service workshop and extension of the QC laboratory.
Expansions in Berlin to include new laboratory space for immunohistochemistry, in situ hybridization and molecular pathology.
Expansion of the Berlin headquarters by 120 square meters of new office space.
Zytomed Systems becomes a member of the ZytoMax group.
Our Austrian branch is established.
Our Swiss branch is established.
Based on our successful development and our strong position in the market, we want to further consolidate and systematically expand our technological leadership in the fields of immunohistology, in situ hybridization, and cell biology research.
Zytomed System is part of the ZytoMax Group. As well as our sister companies ZytoVision and 42 life sciences. We introduce our management team of the ZytoMax Group:
VP Sales DACH
VP Marketing & Clinical Application
VP QM & Regulatory Affairs
VP Sales International
VP Research and Development